HomeQuestion

Are there concerns with using intranasal DDAVP if available since the Stimate recall?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How do you manage bleeding or peri-procedural care for vWD patients whose vWF levels have increased or normalized from age or hormonal contraceptive use?

What is the best way to prepare children with von Willebrand disease for tonsillectomy to reduce the risk of post-operative hemorrhage?

What are your top takeaways in Hematologic Malignancies from ASH 2025?

What is your preferred treatment agent for type 1 von Willebrand patients needing minor procedures if they have a history of severe hyponatremia with DDAVP?

How do you approach the treatment of HSCT-associated thrombotic microangiopathy?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.

Are there concerns with using intranasal DDAVP if available since the Stimate recall? | Mednet